Patent Assignment
Reel/Frame 026324/0984
Merger
Recorded: 2011-05-23
Pages: 7
Assignor
CURNA, INC.
Executed: 2011-01-31
Assignee
OPKO CURNA, LLC
4400 BISCAYNE BOULEVARD, IP-LEGAL DEPARTMENT, MIAMI, FLORIDA, 33137
Covered Properties
(21)
Treatment of SIRTUIN3 (SIRT3) Related Diseases by Inhibition of Natural Antisense Transcript to SIRTUIN3
Application:
61/330,427 →
Treatment of NK6 Homeobox 1 (NKX6-1) Related Diseases by Inhibition of Natural Antisense Transcript to NKX6-1
Application:
61/323,027 →
Treatment of Pancreatic and Duodenal Homeobox 1 (PDX1) Related Diseases by Inhibition of Natural Antisense Transcript to PDX1
Application:
61/297,863 →
Treatment of V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog a (Mafa) Related Diseases by Inhibition of Natural Antisense Transcript to Mafa
Application:
61/297,847 →
Treatment of Hepatocyte Nuclear Factor 4, Alpha (HNF4A) Related Diseases by Inhibition of Natural Antisense Transcript to HNF4A
Application:
61/294,129 →
Treatment of Sex Hormone Binding Globulin (Shbg) Related Diseases by Inhibition of Natural Antisense Transcript to Shbg
Application:
61/293,739 →
Treatment of Neurogenic Differentiation Factor 1 (NEUROD1) Related Diseases by Inhibition of Natural Antisense Transcript to NEUROD1
Application:
61/292,508 →
Treatment of Interferon Regulatory Factor 8 (IRF8) Related Diseases by Inhibition of Natural Antisense Transcript to IRF8
Application:
61/291,946 →
Treatment of Insulin Receptor Substrate 2 (IRS2) Related Diseases by Inhibition of Natural Antisense Transcript to IRS2 or Transcription Factor E3 (TFE3)
Application:
61/291,419 →
Treatment of Nuclear Respiratory Factor 1 (NRF1) Related Diseases by Inhibition of Natural Antisense Transcript to NRF1
Application:
61/290,549 →
TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
Application:
61/290,540 →
Treatment of Hepatocyte Growth Factor (Hgf) Related Diseases by Inhibition of Natural Antisense Transcript to Hgf
Application:
61/289,647 →
Treatment of Uncoupling Protein 2 (UCP2) Related Diseases by Inhibition of Natural Antisense Transcript to UCP2
Application:
61/289,538 →
Treatment of Membrane Bound Transcription Factor Peptidase, Site 1 (MBTPS1) Related Diseases by Inhibition of Natural Antisense Transcript to MBTPS1
Application:
61/286,924 →
Treatment of Hemoglobin (Hbf/Hbg) Related Diseases by Inhibition of Natural Antisense Transcript to Hbf/Hbg
Treatment of Apolipoprotein-A1 Related Diseases by Inhibition of Natural Antisense Transcript to Apolipoprotein-A1
Treatment of Utrophin (Utrn) Related Diseases by Inhibition of Natural Antisense Transcript to Utrn
Application:
61/317,350 →
Treatment of Filaggrin (Flg) Related Diseases by Inhibition of Natural Antisense Transcript to Flg
Application:
61/307,654 →
Treatment of Collagen Alpha-1(I) (COL1A1) Related Diseases by Inhibition of Natural Antisense Transcript to COL1A1
Application:
61/286,965 →
Treatment of Collagen Alpha-2(I) (COL1A2) Related Diseases by Inhibition of Natural Antisense Transcript to COL1A2
Application:
61/286,939 →
Treatment of POU5F1 Related Diseases by Inhibition of Natural Antisense Transcript to POU5F1
Application:
61/286,852 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.